pLenti-CMV-Blast-PIP-FUCCI Citations (10)
Originally described in: Accurate delineation of cell cycle phase transitions in living cells with PIP-FUCCI.Grant GD, Kedziora KM, Limas JC, Cook JG, Purvis JE Cell Cycle. 2018;17(21-22):2496-2516. doi: 10.1080/15384101.2018.1547001. PubMed Journal
Articles Citing pLenti-CMV-Blast-PIP-FUCCI
| Articles |
|---|
| LIN37-DREAM prevents DNA end resection and homologous recombination at DNA double-strand breaks in quiescent cells. Chen BR, Wang Y, Tubbs A, Zong D, Fowler FC, Zolnerowich N, Wu W, Bennett A, Chen CC, Feng W, Nussenzweig A, Tyler JK, Sleckman BP. Elife. 2021 Sep 3;10. pii: 68466. doi: 10.7554/eLife.68466. PubMed |
| Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer. Sela Y, Li J, Maheswaran S, Norgard R, Yuan S, Hubbi M, Doepner M, Xu JP, Ho ES, Mesaros C, Sheehan C, Croley G, Muir A, Blair IA, Shalem O, Dang CV, Stanger BZ. Cancer Res. 2022 May 16;82(10):1890-1908. doi: 10.1158/0008-5472.CAN-22-0431. PubMed |
| EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities. Yedier-Bayram O, Gokbayrak B, Kayabolen A, Aksu AC, Cavga AD, Cingoz A, Kala EY, Karabiyik G, Gunsay R, Esin B, Morova T, Uyulur F, Syed H, Philpott M, Cribbs AP, Kung SHY, Lack NA, Onder TT, Bagci-Onder T. Cell Death Dis. 2022 Aug 16;13(8):710. doi: 10.1038/s41419-022-05146-4. PubMed |
| The EMT transcription factor ZEB1 governs a fitness-promoting but vulnerable DNA replication stress response. Schuhwerk H, Kleemann J, Gupta P, van Roey R, Armstark I, Kreileder M, Feldker N, Ramesh V, Hajjaj Y, Fuchs K, Mahapatro M, Hribersek M, Volante M, Groenewoud A, Engel FB, Ceppi P, Eckstein M, Hartmann A, Muller F, Kroll T, Stemmler MP, Brabletz S, Brabletz T. Cell Rep. 2022 Dec 13;41(11):111819. doi: 10.1016/j.celrep.2022.111819. PubMed |
| Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. Alghoul E, Paloni M, Takedachi A, Urbach S, Barducci A, Gaillard PH, Basbous J, Constantinou A. Mol Cell. 2023 May 18;83(10):1640-1658.e9. doi: 10.1016/j.molcel.2023.03.021. Epub 2023 Apr 13. PubMed |
| Nucleotide depletion promotes cell fate transitions by inducing DNA replication stress. Do BT, Hsu PP, Vermeulen SY, Wang Z, Hirz T, Abbott KL, Aziz N, Replogle JM, Bjelosevic S, Paolino J, Nelson SA, Block S, Darnell AM, Ferreira R, Zhang H, Milosevic J, Schmidt DR, Chidley C, Harris IS, Weissman JS, Pikman Y, Stegmaier K, Cheloufi S, Su XA, Sykes DB, Vander Heiden MG. Dev Cell. 2024 May 30:S1534-5807(24)00327-7. doi: 10.1016/j.devcel.2024.05.010. PubMed |
| LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast Cancer. Zhang Q, Wang X, Shao Z, Zhang Y, Zhang L, Chen M, Zhou X, Zhu H, Zhou Y, Lu X, Li P, Chi W, Li L, Shao ZM, Huang S, Xue J, Chi Y, Wu J, Xiu B. Adv Sci (Weinh). 2025 Apr;12(14):e2413527. doi: 10.1002/advs.202413527. Epub 2025 Feb 14. PubMed |
| Multimodal Nanoplasmonic and Fluorescence Imaging for Simultaneous Monitoring of Single-Cell Secretory and Intracellular Dynamics. Ansaryan S, Chiang YC, Liu YC, Reichenbach P, Irving M, Altug H. Adv Sci (Weinh). 2025 Apr;12(16):e2415808. doi: 10.1002/advs.202415808. Epub 2025 Mar 5. PubMed |
| Piperazine-Substituted Pyranopyridines Exhibit Antiproliferative Activity and Act as Inhibitors of HBV Virion Production. Buloyan S, Harutyunyan A, Gasparyan H, Sakeyan A, Shahkhatuni A, Zakirova NF, Yusubalieva G, Kirillov IM, Fedyakina IT, Solyev PN, Lipatova AV, Bogomolov MA, Prassolov VS, Lebedev TD, Ivanov AV. Int J Mol Sci. 2025 Apr 23;26(9):3991. doi: 10.3390/ijms26093991. PubMed |
| A high-resolution, nanopore-based artificial intelligence assay for DNA replication stress in human cancer cells. Jones MJK, Rai SK, Pfuderer PL, Bonfim-Melo A, Pagan JK, Clarke PR, Totanes FIG, Merrick CJ, McClelland SE, Boemo MA. Nat Commun. 2025 Aug 19;16(1):7732. doi: 10.1038/s41467-025-63168-w. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.